Bulletin
Investor Alert

New York Markets Close in:

Annovis Bio Inc.

NYS: ANVS

GO
/marketstate/country/us

Market open

 --Real time quotes

Jan 18, 2022, 11:42 a.m.

/zigman2/quotes/216213707/composite

$

14.79

Change

-0.73 -4.70%

Volume

Volume 65,379

Real time quotes

/zigman2/quotes/216213707/composite

Previous close

$ 15.52

$ 14.79

Change

-0.73 -4.70%

Day low

Day high

$14.10

$15.48

Open

52 week low

52 week high

$9.62

$132.00

Open

Mark White

Mark White is on the board of Annovis Bio, Inc.

He previously was Chief Executive Officer at Neurokine Therapeutics LLC, Senior Director & Group Leader-Pain Therapeutics at Pfizer Inc. and Senior Director-Marketing & Business Development at Bracco Diagnostics, Inc.

Mark White received an undergraduate degree and a graduate degree from the University of Missouri and an MBA from The University of Chicago Booth School of Business.

Transactions

Date Shares Transaction Value
10/12/2021 5,000   Acquisition at $27.4 per share. 137,000
01/31/2020 3,252   Derivative/Non-derivative trans. at $4.8 per share. 15,609
01/31/2020 34,643   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 11,548   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 1,734   Acquisition at $6 per share. 10,404

Officers and Executives

Dr. Maria-Luisa Maccecchini
President, Chief Executive Officer & Director
Mr. Jeffrey B. McGroarty
Chief Financial Officer
Ms. Cheng Fang
Vice President-Research
Mr. Michael B. Hoffman
Chairman
Mr. Reid S. McCarthy
Independent Director
Dr. Claudine E. Bruck
Independent Director
Mr. Mark White
Independent Director
Link to MarketWatch's Slice.